F008 Pediatric Dermatological Laser Surgery Pearls
DESCRIPTION
Get laser-focused and join leading national experts in pediatric dermatology for an interactive two-hour forum highlighting state-of-the-art advances in pediatric laser surgery. This session explores cutting-edge techniques and emerging treatment protocols tailored specifically for pediatric and adolescent patients. Key topics include novel approaches for complex hypertrophic burn scars, vascular anomalies, pigmented lesions, and challenging genodermatoses. Attendees will gain actionable clinical insights, procedural pearls, and practical guidance on optimizing outcomes and patient safety in pediatric laser care.
LEARNING OBJECTIVES
Formulate a pre-operative, intra-operative, and post-operative approach to children in need of laser surgery; learn what is "on the horizon" in terms of laser surgery for kids.
Demonstrate pediatric-specific laser surgery techniques.
Develop practical skills to enhance laser safety in pediatric patients.
SCHEDULE
9:00 AM
Introduction
Andrew C. Krakowski, MD, FAAD
9:05 AM
Port Wine Capillary Malformations
Kristen Marie Kelly, MD, FAAD
9:21 AM
Infantile Hemangiomas (Early versus Late Treatment) and PDL for Basal Cell Nevus Syndrome
Maria Gnarra Buethe, MD, PhD, FAAD
9:37 AM
Other Vascular Lesions (e.g., RASA1, lymphangiomas, venous malformations)
Joyce Teng, MD, FAAD
9:53 AM
Congenital Nevi and Neurofibromas
Yakir S. Levin, MD, PhD, FAAD
10:09 AM
Nevus Sebaceous and Hypertrophic Scars
Sandy Sharon Tsao, MD, FAAD
10:25 AM
Hemoporfin-Mediated Photodynamic Therapy for Port Wine Capillary Malformations
Andrew C. Krakowski, MD, FAAD
10:30 AM
Cases Submitted by SPD Members
10:50 AM
Interactive Audience Discussion
DIRECTOR
Andrew C. Krakowski, MD, FAAD
St. Luke's University Health Network
SPEAKERS
Maria Gnarra Buethe, MD, PhD, FAAD
Kristen Marie Kelly, MD, FAAD
University of California, Irvine
Yakir S. Levin, MD, PhD, FAAD
Joyce Teng, MD, FAAD
DISCLOSURES
Maria Gnarra Buethe, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Kristen Marie Kelly, MD, FAAD
BioPhotas Inc. – Investigator(Grants/Research Funding); Candela Corporation – Investigator(Grants/Research Funding), Other(Equipment); Cutera – Advisory Board(Honoraria), Other(Equipment); Lutronic – Investigator(Equipment), Investigator(Grants/Research Funding); Michelson Diagnostics – Investigator(Grants/Research Funding); Primus Pharmaceuticals – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Reliant Technologies, Inc. – Other(Equipment); Sciton Inc. – Investigator(Equipment); Sciton, Inc. – Consultant(Honoraria); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Thermage – Other(Equipment);
Andrew C. Krakowski, MD, FAAD
Conscience LLC – Founder(Other Financial Benefit);
Yakir S. Levin, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Joyce Teng, MD, FAAD
Abeona – Consultant(Fees); AFT Pharmaceuticals – Consultant(Fees); Amryt Pharma – Consultant(Fees); Eden Brand – Advisory Board(Fees); Novartis – Investigator(Grants/Research Funding); Palvella Therapeutics – Consultant(Fees);